- Correspondence to Dr Robert M Nelson, Office of Pediatric Therapeutics, Office of the Commissioner, Food and Drug Administration, WO32–5152, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
- Received April 6, 2016
- Revised March 23, 2017
- Accepted April 18, 2017
- First published May 15, 2017.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.